| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 4/9/2024 | $17.00 | Overweight | Piper Sandler |
Piper Sandler initiated coverage of NB Bancorp with a rating of Overweight and set a new price target of $17.00
NEEDHAM, Mass., Oct. 30, 2024 /PRNewswire/ -- NB Bancorp, Inc. (the "Company") (Nasdaq Capital Market: NBBK), the holding company of Needham Bank (the "Bank"), today announced its third quarter 2024 financial results. SELECTED FINANCIAL HIGHLIGHTS FOR THE THIRD QUARTER OF 2024 Net income of $8.4 million, or $0.21 per diluted share, compared to net income of $9.5 million, or $0.24 per diluted share, for the prior quarter. Operating net income, excluding one-time charges, amounted to $13.1 million, or $0.33 per diluted share for the current quarter. One-time charges include:Loss on the sale of available-for sale securities amounting to $1.9 million;Tax expense and a modified endowment contrac
NEEDHAM, Mass., July 24, 2024 /PRNewswire/ -- NB Bancorp, Inc. (the "Company") (Nasdaq Capital Market: NBBK), the holding company of Needham Bank, today announced its second quarter 2024 financial results. SELECTED FINANCIAL HIGHLIGHTS FOR THE SECOND QUARTER OF 2024 Net income of $9.5 million, or $0.24 per diluted share, compared to net income of $8.7 million, or $0.22 per diluted share, for the prior quarter.Gross loans increased $142.7 million, or 3.6%, to $4.10 billion, from the prior quarter.Net interest margin on a fully-tax equivalent basis decreased 15 basis points to 3.45%.Asset quality remains strong:Annualized net charge-offs of 0.09% of average total loans and non-performing loan
Matthew Cohn of Philadelphia will head the non-profit's volunteer-led Global Mission Board which focuses on special initiatives in type 1 diabetes research, fundraising, community engagement, and advocacy NEW YORK, July 10, 2024 /PRNewswire/ -- Breakthrough T1D, formerly JDRF, the leading global type 1 diabetes (T1D) research and advocacy organization, today announced the appointment of Matthew Cohn as the new chair of the non-profit's Global Mission Board. Breakthrough T1D's Global Mission Board is a volunteer-led group, appointed by the organization's board of directors, that focuses on special initiatives in type 1 diabetes research, fundraising, community engagement and advocacy. Matthew
NEEDHAM, Mass., Feb. 28, 2024 /PRNewswire/ -- NB Bancorp, Inc. (the "Company") (Nasdaq Capital Market: NBBK), the holding company of Needham Bank, today announced its 2023 financial results. Concurrent with its mutual-to-stock conversion and as described in the prospectus for its initial public offering ("IPO"), the Company made a one-time donation of $2.0 million in cash and 1.7 million shares of common stock to the Needham Bank Charitable Foundation at a total market value of $19.1 million. This contribution, in addition to a one-time conversion and IPO-related compensation, pension termination expense and tax expense related to the impact of public company tax laws resulted in net income
8-K - NB Bancorp, Inc. (0001979330) (Filer)
8-K - NB Bancorp, Inc. (0001979330) (Filer)
8-K - NB Bancorp, Inc. (0001979330) (Filer)
10-Q - NB Bancorp, Inc. (0001979330) (Filer)
8-K - NB Bancorp, Inc. (0001979330) (Filer)
8-K - NB Bancorp, Inc. (0001979330) (Filer)
11-K - NB Bancorp, Inc. (0001979330) (Filer)
8-K - NB Bancorp, Inc. (0001979330) (Filer)
8-K - NB Bancorp, Inc. (0001979330) (Filer)
10-Q - NB Bancorp, Inc. (0001979330) (Filer)
SC 13G - NB Bancorp, Inc. (0001979330) (Subject)
SC 13G/A - NB Bancorp, Inc. (0001979330) (Subject)
SC 13G/A - NB Bancorp, Inc. (0001979330) (Subject)
SC 13G - NB Bancorp, Inc. (0001979330) (Subject)
4 - NB Bancorp, Inc. (0001979330) (Issuer)
4 - NB Bancorp, Inc. (0001979330) (Issuer)
4 - NB Bancorp, Inc. (0001979330) (Issuer)
4 - NB Bancorp, Inc. (0001979330) (Issuer)
4 - NB Bancorp, Inc. (0001979330) (Issuer)
4 - NB Bancorp, Inc. (0001979330) (Issuer)
4 - NB Bancorp, Inc. (0001979330) (Issuer)
4 - NB Bancorp, Inc. (0001979330) (Issuer)
4 - NB Bancorp, Inc. (0001979330) (Issuer)
4 - NB Bancorp, Inc. (0001979330) (Issuer)
NEEDHAM, Mass., Oct. 30, 2024 /PRNewswire/ -- NB Bancorp, Inc. (the "Company") (Nasdaq Capital Market: NBBK), the holding company of Needham Bank (the "Bank"), today announced its third quarter 2024 financial results. SELECTED FINANCIAL HIGHLIGHTS FOR THE THIRD QUARTER OF 2024 Net income of $8.4 million, or $0.21 per diluted share, compared to net income of $9.5 million, or $0.24 per diluted share, for the prior quarter. Operating net income, excluding one-time charges, amounted to $13.1 million, or $0.33 per diluted share for the current quarter. One-time charges include:Loss on the sale of available-for sale securities amounting to $1.9 million;Tax expense and a modified endowment contrac
NEEDHAM, Mass., July 24, 2024 /PRNewswire/ -- NB Bancorp, Inc. (the "Company") (Nasdaq Capital Market: NBBK), the holding company of Needham Bank, today announced its second quarter 2024 financial results. SELECTED FINANCIAL HIGHLIGHTS FOR THE SECOND QUARTER OF 2024 Net income of $9.5 million, or $0.24 per diluted share, compared to net income of $8.7 million, or $0.22 per diluted share, for the prior quarter.Gross loans increased $142.7 million, or 3.6%, to $4.10 billion, from the prior quarter.Net interest margin on a fully-tax equivalent basis decreased 15 basis points to 3.45%.Asset quality remains strong:Annualized net charge-offs of 0.09% of average total loans and non-performing loan
Matthew Cohn of Philadelphia will head the non-profit's volunteer-led Global Mission Board which focuses on special initiatives in type 1 diabetes research, fundraising, community engagement, and advocacy NEW YORK, July 10, 2024 /PRNewswire/ -- Breakthrough T1D, formerly JDRF, the leading global type 1 diabetes (T1D) research and advocacy organization, today announced the appointment of Matthew Cohn as the new chair of the non-profit's Global Mission Board. Breakthrough T1D's Global Mission Board is a volunteer-led group, appointed by the organization's board of directors, that focuses on special initiatives in type 1 diabetes research, fundraising, community engagement and advocacy. Matthew
4 - NB Bancorp, Inc. (0001979330) (Issuer)
4 - NB Bancorp, Inc. (0001979330) (Issuer)
4 - NB Bancorp, Inc. (0001979330) (Issuer)
3 - NB Bancorp, Inc. (0001979330) (Issuer)
4 - NB Bancorp, Inc. (0001979330) (Issuer)
4 - NB Bancorp, Inc. (0001979330) (Issuer)
4 - NB Bancorp, Inc. (0001979330) (Issuer)
4 - NB Bancorp, Inc. (0001979330) (Issuer)
4 - NB Bancorp, Inc. (0001979330) (Issuer)
4 - NB Bancorp, Inc. (0001979330) (Issuer)
Piper Sandler analyst Mark Fitzgibbon maintains NB Bancorp (NASDAQ:NBBK) with a Overweight and raises the price target from $17 to $20.
NB Bancorp (NASDAQ:NBBK) reported quarterly earnings of $0.24 per share which beat the analyst consensus estimate of $0.23 by 4.35 percent. The company reported $41.70 million in sales this quarter. This is a 19.71 percent increase over sales of $34.84 million the same period last year.
Piper Sandler analyst Mark Fitzgibbon initiates coverage on NB Bancorp (NASDAQ:NBBK) with a Overweight rating and announces Price Target of $17.
Although U.S. stocks closed higher on Tuesday, there were a few notable insider trades. When insiders purchase shares, it indicates their confidence in the company's prospects or that they view the stock as a bargain. Either way, this signals an opportunity to go long on the stock. Insider purchases should not be taken as the only indicator for making an investment or trading decision. At best, it can lend conviction to a buying decision. Below is a look at a few recent notable insider purchases. For more, check out Benzinga's insider transactions platform. Advance Auto Parts The Trade: Advance Auto Parts, Inc. (NYSE:AAP) Director Brent Windom acquired a total of 2,683 shares an
Companies Reporting Before The Bell • Frontline (NYSE:FRO) is expected to report quarterly earnings at $0.46 per share on revenue of $276.19 million. • NB Bancorp (NASDAQ:NBBK) is likely to report earnings for its Fiscal Year 2023. • Verona Pharma (NASDAQ:VRNA) is projected to report quarterly loss at $0.26 per share on revenue of $0. • iHuman (NYSE:IH) is estimated to report earnings for its fourth quarter. • argenx (NASDAQ:ARGX) is estimated to report quarterly loss at $1.71 per share on revenue of $364.75 million. • Titan Intl (NYSE:TWI) is expected to report quarterly earnings at $0.28 per share on revenue of $413.57 million. • Canadian Imperial Bank (NYSE:CM) is projected to repo
Total assets were $4.53 billion as of December 31, 2023, representing an increase of $941.1 million, or 26.2%, from December 31, 2022.